Purchases and Sales Made in Q3 2021 in Celyad Oncology Sa (CYAD)
This table provides information about the institutional ownership of Celyad Oncology Sa (CYAD) during Q3 2021. The information is specifically focused on institutions that hold shares of Celyad Oncology SA.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 15, 2021
Q3 2021
|
Morgan Stanley
New York, NY |
BUY
|
- |
24.8KNew |
$96.3K - $130K
|
24.8K
$12.9K
|
|
|
Nov 15, 2021
Q3 2021
|
Ubs Group Ag
|
BUY
|
- |
3.34K+ 315.52% |
$12.9K - $17.5K
|
4.39K
$2.28K
|
|
|
Nov 12, 2021
Q3 2021
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
3KNew |
$11.6K - $15.8K
|
3K
$1.56K
|
|
|
Nov 05, 2021
Q3 2021
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
1.88KNew |
$7.29K - $9.87K
|
1.88K
$978
|
|
|
Nov 15, 2021
Q3 2021
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1.45K+ 22.79% |
$5.61K - $7.59K
|
7.79K
$4.05K
|
|
|
Nov 09, 2021
Q3 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 12, 2021
Q3 2021
|
Old Mission Capital LLC
|
SELL
|
- |
-11.3KClosed |
$43.9K - $59.4K
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Endurant Capital Management LP
San Mateo, CA |
SELL
|
- |
-15.3K- 9.53% |
$59.4K - $80.4K
|
145K
$75.6K
|
|
|
Nov 02, 2021
Q3 2021
|
Victory Capital Management Inc
|
SELL
|
- |
-79.9KClosed |
$310K - $419K
|
0
$0
|